期刊文献+

中西医结合治疗多囊卵巢综合征的临床观察

Clinical Observation on the Treatment of Polycystic Ovary Syndrome With Integrated Traditional Chinese and Western Medicine
下载PDF
导出
摘要 目的探讨中西医结合治疗多囊卵巢综合征的临床应用价值。方法选择2013年3月~2015年2月经我院确诊的多囊卵巢综合征65例患者。对照组32例,采用达英-35联合来曲唑治疗,观察组33例在对照组治疗的基础上加用补肾活血方。结果治疗后,观察组妊娠率高于对照组,中医证候评分及子宫内膜厚度低于对照组,差异均有统计学意义(P〈0.05)。结论中西医结合治疗可改善多囊卵巢综合征患者的激素水平及症状、减小子宫内膜厚度,提高妊娠率。 Objective To explore the clinical application value of Traditional Chinese and Western medicine in the treatment of polycystic ovary syndrome. Methods 65 cases of polycystic ovary syndrome were diagnosed in our hospital from March 2013 to February 2015. Control group(32 cases) was treated with Diane-35 combined to letrozole, observe group(33 cases) was treated with Bushen Huoxue Decoction and iane-35 combined to letrozole. Results After treatment, pregnancy rate in the observation group was higher than that in the control group, TCM syndrome score and endometrial thickness were lower than the control group, the differences were statistically significant(P0.05). Conclusion The combination of traditional Chinese and Western medicine can improve the hormone levels and symptoms of polycystic ovary syndrome patients, reduce the endometrial thickness, and improve the pregnancy rate.
作者 李静
出处 《中国继续医学教育》 2016年第8期192-193,共2页 China Continuing Medical Education
关键词 多囊卵巢综合征 中西医结合 补肾活血 来曲唑 Polycystic ovary syndrome Traditional Chinese and Western medicine Invigorating kidney and promoting blood circulation Letrozole
  • 相关文献

参考文献6

二级参考文献98

  • 1李梅,李志凌,李红发.多囊卵巢综合征卵泡闭锁调节机制的研究进展[J].生殖医学杂志,2004,13(6):377-380. 被引量:14
  • 2苏庆军,唐茂林,王一男,陈建国,王红雷,葛德元.女性痤疮患者血清性激素水平的变化[J].华北国防医药,2006,18(3):212-213. 被引量:7
  • 3李智珍,池凤好,范瑞强.滋阴清肝消痤方配合痤灵酊治疗成年女性痤疮52例[J].中医杂志,2006,47(12):932-932. 被引量:2
  • 4梁竹巍,王蕊.二甲双胍治疗多囊卵巢综合征新进展[J].国外医学(妇产科学分册),2006,33(6):414-417. 被引量:19
  • 5Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, et a! ( eds ). Polycystic Ovary Syndrome. Oxford: Blackwell Scientific Publications, 1992,1997:377-384.
  • 6Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Working Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod, 2004, 19:41 47.
  • 7Azziz R, Cannina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome : the complete task force report. Fertil Steril, 2009,91:456-488.
  • 8American College of Obstetricians and Gynecologists. ACOG practice bulletin. Polycystic ovary syndrome. Obstet Gynecol, 2009, 114 : 936- 949.
  • 9Asunci6n M, Calvo RM, San MillOn JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrino! Metab, 2000,85:2434-2438.
  • 10Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endoerinol Metab, 2004,89 : 2745-2749.

共引文献189

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部